Baclofen (Lioresal Intrathecal, Lioresal) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Also sold as: Lioresal Intrathecal, Lioresal, Lioresal D.s.
Some Baclofen products are in shortage in Canada (1 of 17 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A muscle relaxant used to relieve muscle spasms and stiffness, often from multiple sclerosis or spinal cord injury.
Products affected
1 / 17
In shortage since
May 26, 2023
Reports on file
46
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
BACLOFEN INJECTION
0.05MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02457059 · since May 26, 2023, no end estimate · Delay in shipping of the drug.
Discontinued
BACLOFEN INTRATHECAL
0.05MG · SOLUTION · AVIR PHARMA INC.
DIN 02485494
Resolved
BACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Jan 8, 2025 · Disruption of the manufacture of the drug.
Resolved
BACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Oct 7, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended Aug 29, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
20MG · TABLET · APOTEX INC
DIN 02139391 · ended May 23, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended May 23, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended May 23, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
20MG · TABLET · APOTEX INC
DIN 02139391 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-BACLOFEN
10MG · TABLET · APOTEX INC
DIN 02139332 · ended Dec 15, 2023 · Disruption of the manufacture of the drug.
Avoided
BACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Nov 30, 2023 · Disruption of the manufacture of the drug.
Resolved
BACLOFEN
10MG · TABLET · SANIS HEALTH INC
DIN 02287021 · ended Nov 23, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
Baclofen is currently affected by an active shortage report filed with Health Canada by HIKMA CANADA LIMITED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Baclofen is classified under “MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS” (ATC M03BX).
Recent changes
No changes recorded yet.
Common questions
What is Baclofen used for?
A muscle relaxant used to relieve muscle spasms and stiffness, often from multiple sclerosis or spinal cord injury.
When will Baclofen be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Baclofen in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.